Sarah E. Michalets
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sarah E. Michalets has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Alison Swaims-Kohlmeier
Affiliations Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, United States of America, Department of GYNOB, Emory University School of Medicine, Atlanta, Georgia, United States of America, Division of HIV Prevention Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
1 shared publication - Ananya Saha
Emory University 2 Department of Biology Atlanta, GA
1 shared publication - Anice C. Lowen
Emory University School of Medicine
1 shared publication - Ariana R. Jimenez
Emory University School of Medicine 1 Department of Microbiology & Immunology Atlanta, GA
1 shared publication - Christopher D. Scharer
Emory University
1 shared publication - Jacob E. Kohlmeier
Emory University School of Medicine 1 Department of Microbiology & Immunology Atlanta, GA
1 shared publication
Latest Publications
- Open Access
- 10 September 2026
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (11)
Upper respiratory tract CD8+ tissue-resident memory T cells protect against viral transmission
Intranasal vaccination elicits CD8 tissue-resident memory T cells (TRM) throughout the respiratory tract that provide cross-protection against heterosubtypic viral strains and reduce immunopathology. We previously demonstrated that CD8 TRM can reduce the probability of respiratory virus transmission and the magnitude of infection, using a murine model of parainfluenza virus transmission. Here, we show that CD8 TRM-mediated protection occurs independently of circulating leukocytes, B cells, or CD4 T cells. Additionally, we investigate the contributions of CD8 TRM in different respiratory tract compartments and illustrate that CD8 TRM in the upper respiratory tract (URT), but not the lower respiratory tract (LRT), become activated and proliferate in response to transmitted virus. Furthermore, we demonstrate that CD8 TRM in the URT alone provide sufficient immune surveillance to prevent propagation of infection after viral transmission. These findings offer insights into the development of T cell–based respiratory virus vaccines and shed light on the critical role of URT CD8 TRM in the prevention of viral transmission.
- 10 September 2026
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (11)
Open AccessUpper respiratory tract CD8+ tissue-resident memory T cells protect against viral transmission
Intranasal vaccination elicits CD8 tissue-resident memory T cells (TRM) throughout the respiratory tract that provide cross-protection against heterosubtypic viral strains and reduce immunopathology. We previously demonstrated that CD8 TRM can reduce the probability of respiratory virus transmission and the magnitude of infection, using a murine model of parainfluenza virus transmission. Here, we show that CD8 TRM-mediated protection occurs independently of circulating leukocytes, B cells, or CD4 T cells. Additionally, we investigate the contributions of CD8 TRM in different respiratory tract compartments and illustrate that CD8 TRM in the upper respiratory tract (URT), but not the lower respiratory tract (LRT), become activated and proliferate in response to transmitted virus. Furthermore, we demonstrate that CD8 TRM in the URT alone provide sufficient immune surveillance to prevent propagation of infection after viral transmission. These findings offer insights into the development of T cell–based respiratory virus vaccines and shed light on the critical role of URT CD8 TRM in the prevention of viral transmission.